🛡️ Just a quick check We’re checking your connection to prevent automated abuse
News
MedPage Today) — PHOENIX — Cardiac microcurrent (C-MIC) therapy may have great promise in heart failure (HF) — almost “too good to be true,” according to early studies. With accruing evidence, C-MIC therapy met more objective criteria…
🛡️ Just a quick check We’re checking your connection to prevent automated abuse
MedPage Today) — A low-calorie diet and exercise reversed early-onset type 2 diabetes for more than half of young adults, the randomized RESET for Remission trial showed. Among 96 participants, the intervention put diabetes into remission for…
Generated October 2026 · Clinical Deep Dive 0 Comments At the American College of Cardiology’s 2026 Scientific Sessions, a trial called SPIRIT-HF delivered a genuinely unsettling result for one of cardiology’s oldest and cheapest drugs. Spironolactone, tested against placebo in patients with heart failure with preserved or mildly reduced ejection fraction…
TOPLINE Users of psychoactive substances ibogaine and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) reported higher rates of adverse health effects, including cardiac symptoms and suicidal thoughts, than users of psilocybin, lysergic acid diethylamide (LSD), or MDMA, a cross-sectional study showed. Psilocybin, LSD, and MDMA were estimated to affect a larger proportion of US adults than ibogaine or 5-MeO-DMT…
MedPage Today) — A hearing aid intervention did not reduce dementia incidence among people with mild cognitive impairment and hearing loss in the CHOICE trial, but a secondary outcome suggested that it may have increased the rate of cognitive…
Weather data could help predict up to three days in advance when the number of out-of-hospital cardiac arrests is likely to rise above average, according to a nationwide study of more than 114,000 cases by researchers from Semmelweis University, the Budapest University of Technology and Economics…
🛡️ Just a quick check We’re checking your connection to prevent automated abuse
Immediate coronary angiography did not improve 30-day survival compared with a deferred strategy in patients without ST-segment elevation on an ECG after out-of-hospital cardiac arrest. These were the main findings of the DISCO trial and a meta-analysis presented in a Hot Line session today at ESC Congress 2026…